4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one

We are 4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one CAS:91526-18-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one
CAS.NO:  91526-18-0
Synonyms:
4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one

Molecular Formula: C5H6O4
Molecular Weight: 130.09900

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point:213.8±32.0 °C at 760 mmHg
Melting point:/
Flash point:92.8±18.6 °C
Refractive index: 1.494

Specification:
Appearance:White powder
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20ºC Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Azilsartan medoxomil CAS:863031-21-4

Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.173194-95-1 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.(S)-2-hydroxy methyl 3-methoxy-3,3-diphenylpropionate CAS:177036-78-1 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.3-bromo-1-propanol CAS:627-18-9 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.